Adjuvant immunotherapy in high-risk stage II melanoma: real-world outcomes from a large multicenter retrospective study
Vincenzo De Falco, Antonino Colloca, Giuseppe Argenziano, Marcella Scala et autres
0 citationsCancer Immunology Immunotherapy
Antonio Maria Grimaldi
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
174Publications signalées
4981Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Melanoma and MAPK PathwaysCancer Immunotherapy and BiomarkersCAR-T cell therapy researchImmunotherapy and Immune ResponsesCutaneous Melanoma Detection and Management
Publications récentes
Clinical activity and safety of nivolumab in combination with ipilimumab in metastatic melanoma: findings from REALIPINIVO, a real-world study
Francesco Caraglia, Giuseppe Argenziano, Marcella Scala, Francesca Sparano et autres
0 citationsFrontiers in Immunology
Cancer in migrant populations: evidence from a regional oncology network
Elisabetta Coppola, Chiara D’Alessio, Gabriele Calvanese, Laura Arenare et autres
0 citationsBMC Public Health
Valutazione delle performance nelle reti oncologiche regionali: il modello ValPe.ROC
Francesco Schiavone, Sandro Pignata, Giorgia Rivieccio, Annaluce Mandiello et autres
0 citationsMECOSAN
Rescue Surgery for Advanced Stage Lung Cancer: A Systematic Review
Beatrice Leonardi, Gaetana Messina, Giuseppe Vicario, Davide Gerardo Pica et autres
3 citationsThoracic Cancer
Combining multiple approaches and omics technologies to detect circulating tumor cells (CTCs): a real clinical application in patients with early-stage non-small-cell lung cancer (NSCLC)?
Noemi Maria Giorgiano, Francesca Pentimalli, Floriana Morgillo, Antonio Maria Grimaldi et autres
0 citationsJournal of Cancer Metastasis and Treatment
Sequencing of Checkpoint or BRAF/MEK Inhibitors on Brain Metastases in Melanoma
Paolo A. Ascierto, Mario Mandalà, Pier Francesco Ferrucci, Massimo Guidoboni et autres
14 citationsNEJM Evidence
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial
Paolo A. Ascierto, Milena Casula, Jenny Bulgarelli, Marina Pisano et autres
96 citationsNature Communications
$$\gamma $$-Ray detection with CsI(Tl) scintillators of the FARCOS array
E. Geraci, G. Cardella, C. Maiolino, N. S. Martorana et autres
4 citationsThe European Physical Journal Plus
Data from Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway
Costanza Maria Cristiani, Alice Turdo, Valeria Ventura, Tiziana Apuzzo et autres
0 citations
Data from Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway
Costanza Maria Cristiani, Alice Turdo, Valeria Ventura, Tiziana Apuzzo et autres
0 citations
CSCs characterization. from Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway
Costanza Maria Cristiani, Alice Turdo, Valeria Ventura, Tiziana Apuzzo et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.